Cargando…
Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission
Chikungunya disease results from an infection with the arbovirus, chikungunya virus (CHIKV). Symptoms of CHIKV include fever and persistent, severe arthritis. In recent years, several antiviral drugs have been evaluated in clinical trials; however, no registered antivirals have been approved for cli...
Autores principales: | Wang, Yu-Ming, Lu, Jeng-Wei, Lin, Chang-Chi, Chin, Yuan-Fan, Wu, Tzong-Yuan, Lin, Liang-In, Lai, Zheng-Zong, Kuo, Szu-Cheng, Ho, Yi-Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126800/ https://www.ncbi.nlm.nih.gov/pubmed/27742486 http://dx.doi.org/10.1016/j.antiviral.2016.10.003 |
Ejemplares similares
-
Suramin Inhibits Chikungunya Virus Entry and Transmission
por: Ho, Yi-Jung, et al.
Publicado: (2015) -
Antiviral activity of nitazoxanide against Morbillivirus infections
por: Stelitano, Debora, et al.
Publicado: (2023) -
Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways
por: Miner, Kent, et al.
Publicado: (2019) -
Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19
por: Pindiprolu, Sai Kiran S.S., et al.
Publicado: (2020) -
The Modulation of Cholesterol Metabolism Is Involved in the Antiviral Effect of Nitazoxanide
por: Fenizia, Claudio, et al.
Publicado: (2021)